The Venovo venous stent system from BD has been revealed as one of the 2020 50th Annual Prix Galien USA award nominees in the “Best Medical Technology” category. The Prix Galien award is among the global health innovation industry’s most renowned honours, recognising outstanding biomedical and medical technology product achievement that improves the human condition.
To qualify, each candidate must be US Food and Drug Administration (FDA) approved for marketing within the last five years and demonstrate tremendous potential to impact human health. Sales data are not considered by the nominating committee in their award nominee selection; only science and health impact.
“As we celebrate 50 years of the Prix Galien process, we are honored to announce this year’s Prix Galien USA nominees, which represent the determination and passion for change that serves as the driving force of life-changing innovation,” said Sue Desmond-Hellmann, former CEO of the Bill & Melinda Gates Foundation, chair of the Prix Galien USA and Prix Galien International Committees. “The Awards Committee applauds the nominees for their commitment to ensure a healthier future for generations to come.”
“While scientific discovery and medical innovation experts continue to fight against the current pandemic, this year’s nominees remind us how their work represents the next chapter of human progress in fighting disease,” said Bruno Cohen, chairman of the Galien Foundation. “As we quickly approach this year’s in-person and digital awards ceremony, the Foundation continues to monitor the COVID-19 pandemic and will support guidelines from the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO).”
The Prix Galien USA Committee is composed of seventeen renowned leaders from the biomedical industry and academia, including five Nobel Laureates, responsible for evaluating nominees. Winners will be announced during the Prix Galien USA Awards Ceremony on 29 October 29 2020 in New York City, USA.
